Huller Kelly, an insider of Globus Medical Inc (GMED), purchased 7,500 shares of the company's stock on November 24, 2025, at a price of $25.96 per share, amounting to a total transaction value of $195,000. Following this acquisition, Kelly now holds a total of 7,500 shares in Globus Medical.
This transaction reflects a personal investment by Kelly, which may indicate confidence in the company's future prospects. Globus Medical operates as a medical device company, headquartered in Audubon, Pennsylvania, and employs approximately 5,300 full-time staff. The firm develops and commercializes solutions for various musculoskeletal conditions, including spinal and orthopedic products.
As of November 27, 2025, Globus Medical has a market capitalisation of $12.3 billion, a price-to-earnings ratio of 28.93, and earnings per share of 3.09. The company is expected to report earnings on February 10, 2026, with an estimated EPS of $1.11 and revenue of $792.3 million, followed by another earnings report on May 1, 2026, with an estimated EPS of $0.91 and revenue of $740.6 million.
Insider transactions, such as this one, are reported to the SEC, providing transparency into executive sentiment regarding company shares. However, investors are advised to consider insider activity in conjunction with broader market data and trends rather than in isolation.